“Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials” (2025) Magna Neurologica, 3(2), pp. 138–149. doi:10.20961/magnaneurologica.v3i2.1929.